Literature DB >> 9587141

Functional analysis of copper homeostasis in cell culture models: a new perspective on internal copper transport.

E D Harris1, Y Qian, E Tiffany-Castiglioni, A R Lacy, M C Reddy.   

Abstract

The movement of copper ions across membrane barriers of vital organs and tissues is a priority topic in nutrition and one for which there continues to be little understanding of the mechanism. Reports of membrane-bound, copper-transporting adenosine triphosphatases (Cu-ATPases) selective for copper ions have brought new focus to the problem and prompted fresh ideas. Using a cell culture model approach, we attempted to learn whether transport into and out of cells depends on a Cu-ATPase. Measurement of transport kinetics in fibroblasts, brain glial cells, neuroblastoma cells, and placental cells showed differences in the rates of copper uptake and response to sulfhydryl reagents. BeWo cells, a human choriocarcinoma placental cell line, behaved as did Menkes fibroblasts by avidly absorbing copper but not releasing copper to the immediate environment. Further tests showed that BeWo cells did not express the transcript for the membrane-bound Cu-ATPase that has been identified with Menkes syndrome. Transcript induction, however, was achieved by growing BeWo cells on porous filters that allowed apical and basolateral surfaces to form. With transcript expression, the cells showed a capacity to release copper into the medium. BeWo cells also synthesized a form of ceruloplasmin whose structure differed from that of the plasma protein and hence may be a product of a different gene. BeWo cells may also express the gene for Wilson disease, thus linking Menkes and Wilson proteins to maternal delivery of copper. We constructed a model in which both ATPases work in concert in a vesicle-based transport mechanism. The vesicle model may help us understand the transport of copper across the placenta and all cells in general.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9587141     DOI: 10.1093/ajcn/67.5.988S

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  6 in total

1.  The ATP7B genetic polymorphisms predict clinical outcome to platinum-based chemotherapy in lung cancer patients.

Authors:  Xiang-Ping Li; Ji-Ye Yin; Ying Wang; Hui He; Xi Li; Wei-Jing Gong; Juan Chen; Chen-Yue Qian; Yi Zheng; Fang Li; Tao Yin; Zhi-Cheng Gong; Bo-Ting Zhou; Yu Zhang; Ling Xiao; Hong-Hao Zhou; Zhao-Qian Liu
Journal:  Tumour Biol       Date:  2014-05-23

2.  The Alzheimer's disease amyloid precursor protein modulates copper-induced toxicity and oxidative stress in primary neuronal cultures.

Authors:  A R White; G Multhaup; F Maher; S Bellingham; J Camakaris; H Zheng; A I Bush; K Beyreuther; C L Masters; R Cappai
Journal:  J Neurosci       Date:  1999-11-01       Impact factor: 6.167

3.  Copper transportion of WD protein in hepatocytes from Wilson disease patients in vitro.

Authors:  G Q Hou; X L Liang; R Chen; L W Tang; Y Wang; P Y Xu; Y R Zhang; C H Ou
Journal:  World J Gastroenterol       Date:  2001-12       Impact factor: 5.742

4.  ATP7B expression is associated with in vitro sensitivity to cisplatin in non-small cell lung cancer.

Authors:  Yoshimasa Inoue; Hozumi Matsumoto; Shunsuke Yamada; Kenji Kawai; Hiroshi Suemizu; Masatoshi Gika; Iwao Takanami; Masato Nakamura; Masayuki Iwazaki
Journal:  Oncol Lett       Date:  2010-03-01       Impact factor: 2.967

5.  Copper-transporting P-type adenosine triphosphatase (ATP7B) is expressed in human breast carcinoma.

Authors:  Atsuko Kanzaki; Masakazu Toi; Nouri Neamati; Hitoshi Miyashita; Masahiro Oubu; Kentaro Nakayama; Hiroko Bando; Kenji Ogawa; Masato Mutoh; Shiro Mori; Kunihiko Terada; Toshihiro Sugiyama; Manabu Fukumoto; Yuji Takebayashi
Journal:  Jpn J Cancer Res       Date:  2002-01

6.  Copper and Trace Elements in Gallbladder form Patients with Wilson's Disease Imaged and Determined by Synchrotron X-ray Fluorescence.

Authors:  Wolf Osterode; Gerald Falkenberg; Fritz Wrba
Journal:  J Imaging       Date:  2021-12-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.